CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung
NCT ID: NCT05306288
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
11935 participants
OBSERVATIONAL
2022-04-07
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
NCT04825834
Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
NCT00745160
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
NCT05708599
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
NCT02273336
Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507
NCT00907699
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals with elevated-risk lung cancer (screening population)
Blood Sample Collection
Subjects enrolled in DELFI-L201 will have blood specimens collected (\~30 mL) at enrollment or up to 30 days after enrollment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Sample Collection
Subjects enrolled in DELFI-L201 will have blood specimens collected (\~30 mL) at enrollment or up to 30 days after enrollment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Ability to understand and provide written informed consent
2. Age ≥ 50 years
3. Current or former smoker
4. ≥ 20 pack-years (pack years = number of packs per day × number of years smoked)
5. An initial or annual follow-up lung cancer screening chest CT planned/scheduled within 30 days after enrollment (i.e., enrollment chest CT scan)
Exclusion Criteria
1. Evidence of any diagnosed cancer (including prior lung cancer) other than non-melanoma skin cancer or carcinoma in situ within 2 years prior to enrollment
2. Prior systemic therapy, definitive therapy, radiation, or surgical resection for any cancer diagnosis within 2 years prior to enrollment (with the exception of surgery for nonmelanoma skin cancer and biopsies)
3. Any history of hematologic malignancy or myelodysplasia within 2 years prior to enrollment
4. Any history of organ tissue transplantation
5. Any history of blood product transfusion within 120 days prior to enrollment
6. Current pregnancy
7. Any condition that in the opinion of the Investigator should preclude the participant's participation in the study
8. Past or current participation in any clinical study sponsored by DELFI Diagnostics or any history of a LDT (Laboratory Developed Test) for early detection of lung cancer by DELFI Diagnostics
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Delfi Diagnostics Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cullman Clinical Trials
Cullman, Alabama, United States
Science 37 (nationwide digital enrollment)
Culver City, California, United States
Providence Facey Medical Foundation
Mission Hills, California, United States
Hoag Hospital
Newport Beach, California, United States
Paradigm Clinical Research Center, Inc.
Redding, California, United States
San Francisco VA
San Francisco, California, United States
Clinical Research of California LLC
Walnut Creek, California, United States
SCL Health Research Institute, St. Mary's
Grand Junction, Colorado, United States
Paradigm Clinical Research Center
Wheat Ridge, Colorado, United States
Stamford Health
Stamford, Connecticut, United States
Advanced Research
Boynton Beach, Florida, United States
Morton Plant Hospital
Clearwater, Florida, United States
SIMEDHealth, LLC
Gainesville, Florida, United States
Galenus Group
Lehigh Acres, Florida, United States
Renstar Medical Research
Ocala, Florida, United States
United Medical Research
Port Orange, Florida, United States
American Clinical Trials, LLC.
Acworth, Georgia, United States
Centricity Research Columbus Piedmont
Columbus, Georgia, United States
ClinCept, LLC
Columbus, Georgia, United States
Coastal Heritage Clinical Research
Hinesville, Georgia, United States
Centricity Research Gwinnett Pulmonology
Lawrenceville, Georgia, United States
Centricity Research Rincon Pulmonology
Rincon, Georgia, United States
OSF Saint Francis Medical Center
Peoria, Illinois, United States
Springfield Clinic
Springfield, Illinois, United States
St. Elizabeth Healthcare
Edgewood, Kentucky, United States
Ochsner
New Orleans, Louisiana, United States
Johns Hopkins
Baltimore, Maryland, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Henry Ford Hospital
Detroit, Michigan, United States
Pulmonary Research Institute of Southeast Michigan
Farmington Hills, Michigan, United States
Minneapolis VA
Minneapolis, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
Hannibal Regional Healthcare System
Hannibal, Missouri, United States
Washington University
St Louis, Missouri, United States
Missouri Baptist Medical Center
St Louis, Missouri, United States
Somnos Clinical Research
Lincoln, Nebraska, United States
Internal Medicine Associate
Bridgeton, New Jersey, United States
CHRISTUS St. Vincent Regional Medical Center
Santa Fe, New Mexico, United States
University of Rochester Medical Center
Rochester, New York, United States
SUNY Upstate Medical University
Syracuse, New York, United States
University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States
Duke University
Durham, North Carolina, United States
Durham VA
Durham, North Carolina, United States
Coastal Carolina Health Care, P.A.
New Bern, North Carolina, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Hightower Clinical
Oklahoma City, Oklahoma, United States
Northwest Research Center
Portland, Oregon, United States
Oregon Health Sciences University
Portland, Oregon, United States
Clinical Research Associates of Central Pa, LLC
DuBois, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Pittsburgh VA Healthcare System
Pittsburgh, Pennsylvania, United States
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Ralph H Johnson VA
Charleston, South Carolina, United States
Medical University of South Carolina
Charleston, South Carolina, United States
LLM Research
Myrtle Beach, South Carolina, United States
Baptist Clinical Research Institute
Memphis, Tennessee, United States
Greater Heights Memorial Pulmonary and Sleep
Houston, Texas, United States
Houston Pulmonary Sleep and Allergy Associates
Houston, Texas, United States
North Houston Cancer Clinics
Huntsville, Texas, United States
CHRISTUS Trinity Clinic Pulmonary Medicine
Irving, Texas, United States
R&H Clinical Research, Inc.
Katy, Texas, United States
Lumi Research
Kingwood, Texas, United States
Central Virginia VA Health System: Hunter Holmes McGuire
Richmond, Virginia, United States
UW Medicine Valley Medical Center
Renton, Washington, United States
Pan American Center for Oncology Trials
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DELFI-L201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.